• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 microRNA 作为动脉粥样硬化生物标志物,以及 miR-126 通过 MAPK 信号通路在动脉粥样硬化进展中的功能作用。

Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway.

机构信息

Department of Cardiology, Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing, China.

出版信息

Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2725-2733.

PMID:28678312
Abstract

OBJECTIVE

Mounting evidence suggests the role of microRNAs (miRNAs) in regulating inflammatory responses in various vascular diseases. Inflammation is the key mechanism leading to atherosclerosis (AS) and various miRNAs are aberrantly expressed in response to AS pathophysiology. However, there are very limited studies that serve to elucidate the role of specific miRNA in in vivo or in vitro AS models.

MATERIALS AND METHODS

Microarray analysis of blood plasma of apolipoprotein deficient (apoE-/-) mice was performed followed by the confirmation using qPCR. Bone marrow mononuclear cells (BMMCs), plasma, and vessel tissue were obtained from apoE-/- mice that were induced with miR-126 mimic or inhibitor. Ox-LDL-induced THP-1 macrophages served as in vitro AS model. The release of inflammatory cytokines was detected using ELISA. The regulatory effect of miR-126 on MAP3K10 was confirmed by luciferase reporter activity and immunohistochemical analyses.

RESULTS

The results showed that the miR-126 exhibited a greater fold change of expression in AS mice. Further, the functional role of miR-126 in atherosclerosis pathophysiology was demonstrated both in vivo and in vitro. miR-126 reduced the cytokine release and also decreased the AS progression. miR-126 was also found to be involved in mitogen-associated protein kinase (MAPK) signaling pathway. MAP3K10 was identified to be a direct target.

CONCLUSIONS

miR-126 might serve as a biomarker of AS and its over-expression might prevent the AS progression and development.

摘要

目的

越来越多的证据表明 microRNAs(miRNAs)在调节各种血管疾病中的炎症反应中发挥作用。炎症是导致动脉粥样硬化(AS)的关键机制,各种 miRNA 在外周动脉疾病的病理生理学过程中表达异常。然而,只有非常有限的研究阐明了特定 miRNA 在体内或体外 AS 模型中的作用。

材料和方法

对载脂蛋白缺陷(apoE-/-)小鼠的血浆进行微阵列分析,然后使用 qPCR 进行验证。从接受 miR-126 模拟物或抑制剂诱导的 apoE-/-小鼠中获得骨髓单核细胞(BMMCs)、血浆和血管组织。用 ox-LDL 诱导 THP-1 巨噬细胞作为体外 AS 模型。使用 ELISA 检测炎症细胞因子的释放。通过荧光素酶报告活性和免疫组织化学分析证实了 miR-126 对 MAP3K10 的调节作用。

结果

结果表明,miR-126 在 AS 小鼠中的表达变化幅度更大。此外,miR-126 在体内和体外均证明了其在动脉粥样硬化发病机制中的功能作用。miR-126 减少了细胞因子的释放,也减少了 AS 的进展。miR-126 还参与丝裂原激活蛋白激酶(MAPK)信号通路。鉴定出 MAP3K10 是其直接靶标。

结论

miR-126 可能作为 AS 的生物标志物,其过表达可能阻止 AS 的进展和发展。

相似文献

1
Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway.鉴定 microRNA 作为动脉粥样硬化生物标志物,以及 miR-126 通过 MAPK 信号通路在动脉粥样硬化进展中的功能作用。
Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2725-2733.
2
Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10.通过靶向 MAP3K10 调节 miRNA-155 在动脉粥样硬化炎症反应中的作用。
PLoS One. 2012;7(11):e46551. doi: 10.1371/journal.pone.0046551. Epub 2012 Nov 26.
3
TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.TUG1 敲低通过上调 miR-133a 靶基因 FGF1 的表达来改善动脉粥样硬化。
Cardiovasc Pathol. 2018 Mar-Apr;33:6-15. doi: 10.1016/j.carpath.2017.11.004. Epub 2017 Dec 2.
4
Geniposide regulates the miR-101/MKP-1/p38 pathway and alleviates atherosclerosis inflammatory injury in ApoE mice.栀子苷通过调控 miR-101/MKP-1/p38 通路缓解载脂蛋白 E 基因敲除小鼠动脉粥样硬化炎症损伤
Immunobiology. 2019 Mar;224(2):296-306. doi: 10.1016/j.imbio.2018.12.005. Epub 2018 Dec 27.
5
Inhibition of microRNA-103 attenuates inflammation and endoplasmic reticulum stress in atherosclerosis through disrupting the PTEN-mediated MAPK signaling.miRNA-103 的抑制通过破坏 PTEN 介导的 MAPK 信号通路来减轻动脉粥样硬化中的炎症和内质网应激。
J Cell Physiol. 2020 Jan;235(1):380-393. doi: 10.1002/jcp.28979. Epub 2019 Jun 24.
6
The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.miR-467b 对载脂蛋白 E 基因敲除小鼠脂蛋白脂肪酶(LPL)表达、促炎细胞因子、血脂水平和动脉粥样硬化病变的影响。
Biochem Biophys Res Commun. 2014 Jan 10;443(2):428-34. doi: 10.1016/j.bbrc.2013.11.109. Epub 2013 Dec 2.
7
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.体内CD40沉默通过NF-κB/miR-125b轴减少实验性动脉粥样硬化的进展,并揭示了动脉粥样硬化发病机制中的新潜在介质。
Atherosclerosis. 2016 Dec;255:80-89. doi: 10.1016/j.atherosclerosis.2016.11.002. Epub 2016 Nov 2.
8
MiR-377 mediates the expression of Syk to attenuate atherosclerosis lesion development in ApoE mice.miR-377 通过调节 Syk 的表达来减轻 ApoE 小鼠动脉粥样硬化病变的发展。
Biomed Pharmacother. 2019 Oct;118:109332. doi: 10.1016/j.biopha.2019.109332. Epub 2019 Aug 22.
9
Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.载脂蛋白E增强单核细胞和巨噬细胞中的微小RNA-146a,以抑制核因子-κB驱动的炎症和动脉粥样硬化。
Circ Res. 2015 Jun 19;117(1):e1-e11. doi: 10.1161/CIRCRESAHA.117.305844. Epub 2015 Apr 22.
10
miR-378a Modulates Macrophage Phagocytosis and Differentiation through Targeting CD47-SIRPα Axis in Atherosclerosis.miR-378a 通过靶向动脉粥样硬化中的 CD47-SIRPα 轴调节巨噬细胞吞噬和分化。
Scand J Immunol. 2019 Jul;90(1):e12766. doi: 10.1111/sji.12766. Epub 2019 Apr 22.

引用本文的文献

1
MiR-126 regulates the effect of mesenchymal stem cell vascular repair on carotid atherosclerosis through MAPK/ERK signaling pathway.微小RNA-126通过丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路调控间充质干细胞血管修复对颈动脉粥样硬化的影响。
World J Stem Cells. 2025 Jun 26;17(6):106520. doi: 10.4252/wjsc.v17.i6.106520.
2
Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.连点成线:微小RNA如何将哮喘与动脉粥样硬化联系起来。
Int J Mol Sci. 2025 Apr 10;26(8):3570. doi: 10.3390/ijms26083570.
3
Involvement of circulating microRNAs in the pathogenesis of atherosclerosis in young patients with obesity.
循环微RNA在肥胖年轻患者动脉粥样硬化发病机制中的作用
Physiol Res. 2024 Dec 31;73(S3):S755-S769. doi: 10.33549/physiolres.935467.
4
Emerging understandings of the role of exosomes in atherosclerosis.对外泌体在动脉粥样硬化中作用的新认识。
J Cell Physiol. 2025 Jan;240(1):e31454. doi: 10.1002/jcp.31454. Epub 2024 Oct 6.
5
miR-328-5p functions as a critical negative regulator in early endothelial inflammation and advanced atherosclerosis.miR-328-5p 在早期血管内皮炎症和晚期动脉粥样硬化中作为关键的负调控因子发挥作用。
BMB Rep. 2024 Aug;57(8):375-380. doi: 10.5483/BMBRep.2024-0055.
6
Irisin: A Potentially Fresh Insight into the Molecular Mechanisms Underlying Vascular Aging.鸢尾素:血管老化潜在分子机制的新视角。
Aging Dis. 2023 Nov 20;15(6):2491-2506. doi: 10.14336/AD.2023.1112.
7
Effects of Exercise on Circulating Extracellular Vesicles in Cardiovascular Disease.运动对心血管疾病患者循环细胞外囊泡的影响。
Adv Exp Med Biol. 2023;1418:241-258. doi: 10.1007/978-981-99-1443-2_16.
8
Evaluation of microRNA Expression Features in Patients with Various Types of Arterial Damage: Thoracic Aortic Aneurysm and Coronary Atherosclerosis.不同类型动脉损伤患者的微小RNA表达特征评估:胸主动脉瘤和冠状动脉粥样硬化
J Pers Med. 2023 Jul 20;13(7):1161. doi: 10.3390/jpm13071161.
9
An updated review on cell signaling pathways regulated by candidate miRNAs in coronary artery disease.关于候选微小RNA调控的冠状动脉疾病细胞信号通路的最新综述
Noncoding RNA Res. 2023 Mar 29;8(3):326-334. doi: 10.1016/j.ncrna.2023.03.007. eCollection 2023 Sep.
10
Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review.与代谢综合征心脏代谢危险因素相关的循环微小RNA:一项系统评价
Metabolites. 2022 Oct 30;12(11):1044. doi: 10.3390/metabo12111044.